Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503724 | SCV000597918 | pathogenic | Cohen syndrome | 2016-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000503724 | SCV002182294 | pathogenic | Cohen syndrome | 2023-04-06 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 437257). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Phe2028Leufs*2) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Gene |
RCV004591446 | SCV005081262 | likely pathogenic | not provided | 2024-04-03 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Counsyl | RCV000503724 | SCV000789554 | likely pathogenic | Cohen syndrome | 2017-02-07 | no assertion criteria provided | clinical testing |